Web3 VCs in Naarden
2 funds and 129 venture capitalists based in Naarden.
Funds
ForbionEst. 2006 · 109 team · 0 investmentsBioGeneration VenturesEst. 2006 · 20 team · 0 investments
Investors
Rachelle YoungInvestor Relations DirectorBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Elisa CamoraniSenior Associate ESG and ImpactBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Cyril LesserVice President Finance | FundsBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Arnoud DijkstraVenture PartnerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Machteld GroeneveldChief Compliance Officer & Legal AffairsBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Oskar SlotboomManaging PartnerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Daniela CoutoGeneral PartnerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Olga ZiessenManager Secretarial ServicesBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Robbert van de GriendtHead of Investor RelationsBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Wouter VerhoevenVenture PartnerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Rianne EllenbroekPrincipalBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
John J.P. KasteleinSenior AdvisorBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Patricia VonkAML/KYC ManagerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Jennifer FritzscheVice President FinanceBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Silva DezelanHead of Impact and ESGBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Karen ChanAssociateBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Dragana DragusinExecutive AssistantBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Elena RitsouVenture PartnerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Maureen WoutersParalegalBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Rob de ReeVenture PartnerBioGeneration Ventures
BGV does not publish a standard current startup check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Dirk KerstenManaging PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Geert-Jan MulderManaging PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Sander SlootwegManaging PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Martien van OschManaging Partner & CFOForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Jon EdwardsGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Nanna LüneborgGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Marco BoorsmaGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Jasper BosGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Joy FaucherGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Alexander HoffmannGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Dmitrij HristodorovGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Wouter JoustraGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Rogier RooswinkelGeneral PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Robbert van de GriendtGeneral Partner IR & ImpactForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Machteld GroeneveldChief Legal Risk & Compliance OfficerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Wilfred KevelamChief Accounting OfficerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Regina SalvatPartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Thijs VerburgPartner, Investor RelationsForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Mathias VintherPartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Audrey CacalyPrincipalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Vanessa CarlePrincipalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Morgan HallerPrincipalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Meike LogtenbergPrincipalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Tim LohoffPrincipalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Carolin LanferSenior AssociateForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Gilles van TienderenSenior AssociateForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Melanie de AlmeidaSenior AssociateForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Kanay KhakhriaSenior AssociateForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Maximilien SouvereynsAssociateForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Luuk de VriesSenior AnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Roberto HofmannSenior AnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Joseph IwasykSenior AnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Sarah NeshatSenior AnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Nat KolberAnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Charlotte KoldeweijAnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Vincent LoonAnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Vivien VeningaAnalystForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
James BayneFellowForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Alice EvansFellow, BioEconomyForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Sebastien GarnierFellow, BioEconomyForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Maja WojtynskaFellowForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Per FalholtOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Rory GummersonOperating Partner, Talent AcquisitionForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Peter Høngaard AndersenOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Carlo IncertiOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
John J.P. KasteleinOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Ton LogtenbergOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
John McDonaldOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
John MontanaOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Gijs van den BrinkOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Sander van DeventerOperating PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Philip Astley-SparkeVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Josh BrummVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Matt CooperVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Cees de JongVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Michael HaydenVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Gökben KocaVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Jonathan McNeillVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Yigal M. PintoVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Patrick RoundVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Onno van de StolpeVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Patrick VinkVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Jens WendlandVenture PartnerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Michael BurgessAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Simon J ClarkAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
John FordAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Scott FriedmanAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Frank G. HolzAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
An MichielsAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Stefan OschmannAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Holger ReithingerSenior AdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Steen RiisgaardAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Liz RodgersAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Floor SarisAdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Feike SijbesmaSenior AdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Alice VickersVenture AdvisorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Laura AsbjornsenHead of Marketing & CommunicationsForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Silva DezelanHead of Impact and ESGForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Jennifer FritzscheVice President FinanceForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Cyril LesserVice President Finance - FundsForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Arjan OosterheertHead of TaxForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Marc van Voorst tot VoorstHead of Public AffairsForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Joost de RijkInvestor Relations DirectorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Lior AlperovichMarketing & Communications DirectorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Vincent ConijnSenior Associate, Impact & ESGForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Bart de JongFinance ManagerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Baris DuvanSenior ParalegalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Marnix GrootFund ControllerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Stijn JochemsenFinance DirectorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Francine MacLeodHR AdministratorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Walter SchramFinance DirectorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Devan SequeiraIT Solution ArchitectForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Thijs van EgmondLegal CounselForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Pascal van WeesFinance DirectorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Iris VeldmanDeal CounselForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Viktorija VodilovskaAI SpecialistForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Patricia VonkAML/KYC ManagerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Maureen WoutersParalegalForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Rachelle YoungInvestor Relations DirectorForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Danielle de MagalhãesExecutive AssistantForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Alicia DortonaOffice ManagerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Dragana DragusinExecutive AssistantForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Tineke DuijnOffice AssistantForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Britt Inga EmersonSenior Executive Assistant, Investor Relations (US)Forbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Tess KegSenior Executive AssistantForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Marijana StojanovicReceptionistForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Chelle TjabringSenior Executive AssistantForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Philippe van SantenFacility ManagerForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics
Olga ZiessenHead Support ServicesForbion
Forbion does not publish one standard current check-size range across its funds on the official site.BiotechnologyLife SciencesTherapeutics